Country and Regional Medicines Projects
WHO coordinates projects that support countries to develop, implement, and monitor national policies and practices and strengthen pharmaceutical systems. The goal: to ensure that high quality essential medicines are available, affordable and used appropriately. We help countries set and agree their medicines priorities, draw up and implement plans, and monitor and evaluate them. We encourage collaboration between countries to improve quality, selection and use, and to increase availability and affordability of medicines. We promote transparency and good governance, and advocate a coordinated, multi-stakeholder approach that involves the private sector, civil society, academic and other partners.
EU/ACP/WHO Renewed Partnership: strengthening pharmaceutical systems to improve access to quality-assured medicines
Expanding access to medicines involves a series of policy developments and reforms in pharmaceutical systems. These include up-to-date essential medicines lists, policies for pricing and reimbursement, policies on responsible prescription and use of medicines, reliable procurement and supply systems, effective regulatory oversight, transparency and good governance in the pharmaceutical sector and regular monitoring of pharmaceutical policies. In 2012, the African Caribbean and Pacific Group of States Secretariat (ACP), the EU and WHO launched the Renewed Partnership, building on their previous programme which ran from 2004-10. The Renewed Partnership supports 15 African countries to strengthening their pharmaceutical systems by providing expertise, knowledge, guidance and training to pharmacists and healthcare policy makers. The programme is due to end in 2016.
Read more about the Renewed Partnership…
The Good Governance for Medicines programme aims to contribute to health systems strengthening by promoting good governance in the pharmaceutical sector. 36 countries and territories have participated in the programme since its inception in 2004.
The MeTA initiative aims to improve access to quality-assured essential medicines in low-income countries through a multi-stakeholder collaboration involving representatives of the public sector, the private sector and civil society. Participating countries include Ghana, Jordan, Kyrgyzstan, Peru, the Philippines, Uganda and Zambia.